25-28 July 2021, Lisboa, Portugal
This conference will provide a unique forum for the research community focusing on translational studies geared towards therapies in AD and related neurodegenerative diseases to come together and to discuss the latest advances and the future challenges in the field.
The talks and poster presentations will include the most updated therapeutic strategies, newly discovered therapeutic targets, and recent clinical developments at various stages in the area of Alzheimer’s and related neurodegenerative diseases. Key topics of discussion will include; BACE1 inhibitors and/or γ-secretase modulators for reducing amyloid deposition, active and passive vaccination for enhancing clearance of amyloid plaques, vaccines for reducing tau pathology, antisense approaches for AD, PD and ALS therapy; neural stem cell approaches for neurodegeneration, inflammatory modulators for neurodegeneration, genetic linkage study and big data approaches and novel therapeutic targets.
Call for Abstracts
Talk Submission 15 February 2021
Poster Submission 28 May 2021
Conference webpage: https://www.fusion-conferences.com/conference/128